Skip to:

    • old men playing chess

Preclinical Alzheimer's Already Affects Nearly 47 Million in US

A study by Dr. Ron Brookmeyer, professor of biostatistics at FSPH, revealed that the number of Alzheimer's cases to double by 2060, was featured in a Reuters Health article.

Tuesday, January 23, 2018

Almost 47 million Americans have brain pathology that places them on a trajectory to Alzheimer's disease (AD), and that number is growing, researchers report.

In what Dr. Brookmeyer and colleagues describe as the first study to provide population-level preclinical disease forecasts, they searched PubMed for worldwide literature about preclinical and clinical AD prevalence.

The researchers used a multistate model of AD progression through eight stages, from normal to late clinical AD. The model incorporated biomarkers for preclinical AD with U.S. population projections, accounting for trends in aging. The findings were published online December 6 in Alzheimer's & Dementia.

Read the full article from Reuters Health